Encephalocraniocutaneous lipomatosis (ECCL) or Haberland syndrome (MIM #613001) is a rare congenital neurocutaneous disorder. It is characterized by unilateral ocular, cutaneous and central nervous system anomalies. Key clinical features include hairless fatty tissue nevus of the scalp, choristoma of the eye and intraspinal and intracerebral lipomas. We report one of the first cases diagnosed after termination of pregnancy at 35 WG, including antenatal and post-mortem imaging, complete autopsy and genetic analysis. Prenatal ultrasound and MRI of the third trimester showed multifocal spinal lesions and left lateral cerebral ventriculomegaly with cerebral atrophy. Diagnosis of ECCL was suggested at complete autopsy which revealed nevus psiloliparus of the scalp, facial hamartomas and intracranial and spinal lipomas. In addition, our case also exhibited a cardiac rhabdomyoma and a multicystic dysplastic kidney, both never reported to date in this syndrome. ECCL was confirmed by the identification of a postzygotic FGFR1 mutation. We reviewed the literature and discuss the pathogenesis of this syndrome.
HaberlandCPerouM.Encephalocraniocutaneous lipomatosis. A new example of ectomesodermal dysgenesis.Arch Neurol. 1970;22:144–55.
2.
Chacon-CamachoOFLopez-MorenoDMorales-SanchezMA, et al. Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies. Mol Genet Genomic Med. 2019;7:e625.
3.
HappleRKüsterW.Nevus psiloliparus: a distinct fatty tissue nevus.Dermatol Basel Switz. 1998;197:6–10.
4.
MoogU.Encephalocraniocutaneous lipomatosis.J Med Genet. 2009;46(11):721–729.
5.
BennettJTTanTYAlcantaraD, et al. Mosaic activating mutations in FGFR1 cause encephalocraniocutaneous lipomatosis.Am J Hum Genet. 2016;98:579–587.
6.
VenotQCanaudG.Segmental overgrowth syndromes and therapeutic strategies. Med Sci. 2020;36:235–242.
7.
RuggieriM, DPraticoA.Mosaic neurocutaneous disorders and their causes.Semin Pediatr Neurol. 2015;22:207–233.
8.
BoppudiSBögershausenNHoveHB, et al. Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis.Clin Genet. 2016;90:334–342.
9.
DoreyKAmayaE.FGF signalling: diverse roles during early vertebrate embryogenesis.Dev Camb Engl. 2010;137:3731–3742.
10.
CirunaBRossantJ.FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev Cell. 2001;1:37–49.
11.
HunterAGW.Oculocerebrocutaneous and encephalocraniocutaneous lipomatosis syndromes: blind men and an elephant or separate syndromes?Am J Med Genet A. 2006;140:709–726.
12.
ÖzdoğanSSaymazCYaltırıkCK, et al. Encephalocraniocutaneous lipomatosis: Haberland syndrome.Am J Case Rep. 2017;18:1271–1275.
13.
TekinBYüceltenADAkpınarINEkinciG.Coexistence of aplasia cutis and nevus psiloliparus – report of a novel case.Pediatr Dermatol. 2014;31:746–748.
14.
HammH.Cutaneous mosaicism of lethal mutations. Am J Med Genet. 1999;85:342–345.
15.
MacLarenMJKluijtIKooleFD.Ophthalmologic abnormalities in encephalocraniocutaneous lipomatosis.Doc Ophthalmol Adv Ophthalmol. 1995;90:87–98.
16.
AlfonsoILopezPFCullenRF, et al. Spinal cord involvement in encephalocraniocutaneous lipomatosis. Pediatr Neurol. 1986;2:380–384.
17.
MoogUJonesMCViskochilDH, et al. Brain anomalies in encephalocraniocutaneous lipomatosis.Am J Med Genet A. 2007;143A:2963–2972.
18.
NowaczykMJMernaghJRBourgeoisJM, et al. Antenatal and postnatal findings in encephalocraniocutaneous lipomatosis. Am J Med Genet. 2000;91:261–266.
19.
JenkinsDMcCuaigC, ADroletB, et al. Tuberous sclerosis complex associated with vascular anomalies or overgrowth.Pediatr Dermatol. 2016;33:536–542.
20.
WalkerKASims-LucasSBatesCM.Fibroblast growth factor receptor signaling in kidney and lower urinary tract development.Pediatr Nephrol. 2016;31:885–895.
21.
XieYSuNYangJ, et al. FGF/FGFR signaling in health and disease. Signal Transduct Target Ther. 2020;5:181.
22.
KotiKBhimireddyVDandamudiSGunnamreddyR.Encephalocraniocutaneous Lipomatosis (Haberl and syndrome): a case report and review of literature. Indian J Dermatol. 2013;58:232–234.
23.
ThakurSThakurVSoodRG, et al. Encephalocraniocutaneous lipomatosis with calvarial exostosis – case report and review of literature.Indian J Radiol Imaging. 2013;23:333–336.
24.
HabibFElsaidMFSalemKY, et al. Oculo-ectodermal syndrome: a case report and further delineation of the syndrome. Qatar Med J. 2014;2014:114–122.
25.
BrownKEGoldsteinSMDouglasRSKatowitzJA.Encephalocraniocutaneous lipomatosis: a neurocutaneous syndrome. J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus. 2003;7:148–149.
FerrantiSSardiIGuidiM, et al. Case report: a case of glioblastoma in a patient with Haberland syndrome. Front Pediatr. 2021;9:648717.
28.
MoogURoelensFMortierGR, et al. Encephalocraniocutaneous lipomatosis accompanied by the formation of bone cysts: harboring clues to pathogenesis?Am J Med Genet A. 2007;143:2973–2980.
29.
GrippKWBakerLKandulaV, et al. Nephroblastomatosis or Wilms tumor in a fourth patient with a somatic PIK3CA mutation.Am J Med Genet A. 2016;170:2559–2569.
30.
SlackJCBründlerMAChangCA, et al. Bilateral nephroblastic tumors and a complex renal vascular anomaly in a patient with a mosaic RASopathy: novel histopathologic features and molecular insights. Pediatr Dev Pathol. 2021;24:235–240.
31.
HomsyYLAndersonJHOudjhaneK, et al. Wilms tumor and multicystic dysplastic kidney disease. J Urol. 1997;158:2256–2259.
